Cristina Tassorelli

TL;DR: The current, fourth edition of the Guidelines for controlled trials of drugs in migraine retains the structure and much content from previous editions, however, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations.

TL;DR: The first edition of the Italian diagnostic and therapeutic guidelines for primary headaches in adults was published in J Headache Pain 2(Suppl. 1):105–190 in 2001 and a section was dedicated to non-pharmacological treatment.

TL;DR: Assessing the possibility of using the nitroglycerin provocative test (NPT) as a supportive measure in the diagnosis of primary neurovascular headaches by assessing its reliability on a large population and adopting strict criteria for rating the response as positive or negative shows it is an easy, low-cost and reliable method.

TL;DR: The full disease phenotype, including progression of ataxia, in 100 confirmed carriers of RFC1 repeat expansions is described, which should be considered in all cases of sensory ataxic neuropathy, particularly if cerebellar dysfunction, cerebellary involvement and cough coexist.

TL;DR: The current state of the art, as well as the challenges faced by, and ideas for, future research on the manipulation of an embodied virtual body in immersive virtual reality for both experimental and clinical pain relief are discussed.